Skip to main content
DNA logo
DNA
(NYSE)
Ginkgo Bioworks Holdings, Inc.
$7.97-- (--)
Loading... - Market loading

Ginkgo Bioworks Holdings (DNA) Stock Price & Financial Analysis

Ginkgo Bioworks Holdings Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$7.49 - $8.37
52-Week High$17.58
52-Week Low$5.37
Open$8.31
Volume1.65M
Average Volume (3M)1.05M
Market Cap474.72M
Shares Outstanding59.56M
Price to Sales (P/S)3.36
Price to Book (P/B)1.07
EV/EBITDA-3.46
Revenue (TTM)141.31M
Net Income (TTM)-304.39M
Free Cash Flow (TTM)-183.27M
EPS (TTM)$-5.40
Profit Margin-215.41%
Operating Margin-210.66%
Return on Equity (ROE)-68.69%
Debt to Equity0.93
50-Day MA$8.76
200-Day MA$8.71
52-Week Change-40.79%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Ginkgo Bioworks Holdings

What is the current stock price for DNA?

As of the latest trading session, DNA stock trades at $7.97. The 52-week range is $5.37–$17.58, with a day range of $7.49–$8.37.

What is the P/E ratio for DNA?

The P/E ratio (Price-to-Earnings) for DNA is shown in the Key Statistics section. This valuation metric helps compare Ginkgo Bioworks Holdings, Inc. to industry peers.

Does DNA pay dividends?

Ginkgo Bioworks Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for DNA?

Analyst ratings and recommendations for DNA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of DNA?

Ginkgo Bioworks Holdings's market capitalization is $474.7M, classifying it as a small-cap company. Ginkgo Bioworks Holdings operates in the Healthcare sector within the Biotechnology industry.